SZSE:300406 (China)
Â
Class A
Â¥
15.04
-0.20 (-1.31%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Beijing Strong Biotechnologies Inc
ISIN : CNE100001Y26
Share Class Description:
SZSE:300406: Class ACompare
Compare
Traded in other countries / regions
300406.China IPO Date
2014-10-30Description
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 1.75 | |||||
| Interest Coverage | 13.87 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.57 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | 6.8 | |||||
| 3-Year EPS without NRI Growth Rate | 9 | |||||
| 3-Year FCF Growth Rate | 25.3 | |||||
| 3-Year Book Growth Rate | 13 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.46 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 10 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.68 | |||||
| 9-Day RSI | 40.81 | |||||
| 14-Day RSI | 42.77 | |||||
| 3-1 Month Momentum % | 41.25 | |||||
| 6-1 Month Momentum % | 30.66 | |||||
| 12-1 Month Momentum % | 0.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.28 | |||||
| Quick Ratio | 8.49 | |||||
| Cash Ratio | 3.75 | |||||
| Days Inventory | 235.13 | |||||
| Days Sales Outstanding | 245.43 | |||||
| Days Payable | 90.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.31 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 26.4 | |||||
| Forward Dividend Yield % | 1.31 | |||||
| 5-Year Yield-on-Cost % | 1.36 | |||||
| Shareholder Yield % | 0.87 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.5 | |||||
| Operating Margin % | 39.79 | |||||
| Net Margin % | 32.11 | |||||
| FCF Margin % | 32.93 | |||||
| ROE % | 13.63 | |||||
| ROA % | 9.94 | |||||
| ROIC % | 13.59 | |||||
| 3-Year ROIIC % | 9.88 | |||||
| ROC (Joel Greenblatt) % | 35.13 | |||||
| ROCE % | 13.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.71 | |||||
| Forward PE Ratio | 16.26 | |||||
| PE Ratio without NRI | 16.53 | |||||
| Shiller PE Ratio | 22.25 | |||||
| Price-to-Owner-Earnings | 18.94 | |||||
| PEG Ratio | 0.89 | |||||
| PS Ratio | 5.36 | |||||
| PB Ratio | 2.14 | |||||
| Price-to-Tangible-Book | 3.68 | |||||
| Price-to-Free-Cash-Flow | 16.46 | |||||
| Price-to-Operating-Cash-Flow | 14.59 | |||||
| EV-to-EBIT | 13.42 | |||||
| EV-to-EBITDA | 13.42 | |||||
| EV-to-Revenue | 5.41 | |||||
| EV-to-FCF | 16.41 | |||||
| Price-to-GF-Value | 0.82 | |||||
| Price-to-Projected-FCF | 1.14 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.88 | |||||
| Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 7.71 | |||||
| Earnings Yield (Greenblatt) % | 7.45 | |||||
| FCF Yield % | 6.17 | |||||
| Forward Rate of Return (Yacktman) % | 22.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Strong Biotechnologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,658.932 | ||
| EPS (TTM) (Â¥) | 0.9 | ||
| Beta | 1.09 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 36.72 | ||
| 14-Day RSI | 42.77 | ||
| 14-Day ATR (Â¥) | 0.721015 | ||
| 20-Day SMA (Â¥) | 15.885 | ||
| 12-1 Month Momentum % | 0.06 | ||
| 52-Week Range (Â¥) | 11.01 - 19.04 | ||
| Shares Outstanding (Mil) | 588.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Strong Biotechnologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Strong Biotechnologies Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Strong Biotechnologies Inc Frequently Asked Questions
What is Beijing Strong Biotechnologies Inc(SZSE:300406)'s stock price today?
The current price of SZSE:300406 is ¥15.04. The 52 week high of SZSE:300406 is ¥19.04 and 52 week low is ¥11.01.
When is next earnings date of Beijing Strong Biotechnologies Inc(SZSE:300406)?
The next earnings date of Beijing Strong Biotechnologies Inc(SZSE:300406) is .
Does Beijing Strong Biotechnologies Inc(SZSE:300406) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Strong Biotechnologies Inc(SZSE:300406) is 1.31% (As of Today), Highest Dividend Payout Ratio of Beijing Strong Biotechnologies Inc(SZSE:300406) was 0.68. The lowest was 0.12. And the median was 0.25. The  Forward Dividend Yield % of Beijing Strong Biotechnologies Inc(SZSE:300406) is 1.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers